Josh Kennedy-Smith

Josh Kennedy-Smith

Analyst-Equity bij RTW Investments LP

Finance
Consumer Services
Health Technology

Profiel

Dr. Joshua Kennedy-Smith is a Managing Director at RTW Investments /Venture/ and a Partner & Research Analyst at RTW Investments LP.
He specializes in the chemistry of small and large molecules, intellectual property, as well as leads our efforts in particular disease and technology areas.
He also leads RTW’s internship and outreach programs.
He has more than a decade of professional experience in the pharmaceutical industry as both a research scientist and manager.
Prior to joining RTW, he served as Principal Scientist and Head of Externalization at Schrodinger.
Josh has experience in the area of inflammation and autoimmune disease and served as a key contributor on a number of kinase inhibitor programs still in development.
He began his career at Roche as a medicinal chemist working on the team that discovered the drug Elpida (elsulfavirine) for HIV.
He received his undergraduate degree from the University of California, Santa Cruz and a doctorate degree from the University of California, Berkeley.

Actieve functies van Josh Kennedy-Smith

BedrijvenFunctieBegin
Analyst-Equity 01-02-2016
Private Equity Investor 01-07-2019
Alle actieve functies van Josh Kennedy-Smith

Eerdere bekende functies van Josh Kennedy-Smith

BedrijvenFunctieEinde
Corporate Officer/Principal -
Ervaring van Josh Kennedy-Smith in detail bekijken

Opleiding van Josh Kennedy-Smith

University of California, Berkeley Doctorate Degree
University of California, Santa Cruz Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Josh Kennedy-Smith in detail bekijken

Connecties

32

Eerstegraads connecties

5

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit3

Finance

Health Technology

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Josh Kennedy-Smith
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU